Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
NSB:ASX
Neuroscientific Biopharmaceuticals Ltd
A$0.094
0.00%
(0.00) 1D
May 22, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NSB...
Open
A$0.10
High
A$0.10
Low
A$0.09
Mkt. cap
31.26M
Avg. vol.
392.95K
Volume
379.15K
52-wk high
A$0.26
52-wk low
A$0.05
EPS
-A$0.02
Shares outstanding
332.58M
News stories
From sources across the web
About Neuroscientific Biopharmaceuticals Ltd
CEO-
Employees-
Founded2002
Headquarters-
SectorBiotechnology
Websiteneuroscientific.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
158.95K
158.95K
Cost of goods sold
-237.00
-237.00
23.53K
23.53K
Cost of revenue
-237.00
-237.00
23.53K
23.53K
Research and development expenses
50.20K
50.20K
225.61K
225.61K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
301.84K
301.84K
409.06K
409.06K
Operating expense
774.66K
774.66K
1.04M
1.04M
Total operating expenses
774.42K
774.42K
1.07M
1.07M
Operating income
-774.42K
-774.42K
-908.64K
-908.64K
Other non operating income
-
-
-
-
EBT including unusual items
-738.98K
-738.98K
-849.71K
-849.71K
EBT excluding unusual items
-738.98K
-738.98K
-849.71K
-849.71K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-738.98K
-738.98K
-849.71K
-849.71K
Net profit margin
-
-
-534.56%
-534.56%
Earnings per share
-
-
-
-
Interest and investment income
35.47K
35.47K
59.20K
59.20K
Interest expense
-24.00
-24.00
-263.00
-263.00
Net interest expenses
35.44K
35.44K
58.94K
58.94K
Depreciation and amortization charges
1.83K
1.83K
383.00
383.00
EBITDA
-750.80K
-750.80K
-597.26K
-597.26K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer